Madhav Vasanthavada

Executive

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 1 saleAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (5 ops.)

€201k

Latest filing published 29 Sept 2026 for Abeona Therapeutics INC., €22k.

Filing timeline

BuySale

Madhav Vasanthavada

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Madhav Vasanthavada: trading record in brief

Madhav Vasanthavada is a declared insider of Abeona Therapeutics Inc., with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 20 January 2026 to 29 September 2026.

Sales make up the whole of the open-market record (5 sales, €201k). Other entries cover 1 share grant.

The record was last updated on 29 September 2026 with an open-market sale (€22k) in Abeona Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.